PMID: 9449278Feb 4, 1998Paper

In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp

Antimicrobial Agents and Chemotherapy
F MarcoR N Jones

Abstract

Voriconazole (formerly UK-109,496) is a new monotriazole antifungal agent which has potent activity against Candida, Cryptococcus, and Aspergillus species. We investigated the in vitro activity of voriconazole compared to those of fluconazole, itraconazole, amphotericin B, and flucytosine (5FC) against 394 bloodstream isolates of Candida (five species) obtained from more than 30 different medical centers. MICs of all antifungal drugs were determined by the method recommended by the National Committee for Clinical Laboratory Standards using RPMI 1640 test medium. Overall, voriconazole was quite active against all the yeast isolates (MIC at which 90% of the isolates are inhibited [MIC90], < or =0.5 microg/ml). Candida albicans was the most susceptible species (MIC90, 0.06 microg/ml) and Candida glabrata and Candida krusei were the least (MIC90, 1 microg/ml). Voriconazole was more active than amphotericin B and 5FC against all species except C. glabrata and was also more active than itraconazole and fluconazole. For isolates of Candida spp. with decreased susceptibility to fluconazole and itraconazole MICs of voriconazole were also higher. Based on these results, voriconazole has promising antifungal activity and further in vitro ...Continue Reading

References

Jan 1, 1995·Antimicrobial Agents and Chemotherapy·J H RexM A Pfaller
Jan 1, 1996·Antimicrobial Agents and Chemotherapy·D GeorgeV T Andriole

❮ Previous
Next ❯

Citations

Feb 28, 2002·Expert Opinion on Investigational Drugs·Holly L Hoffman, R Chris Rathbun
Jun 20, 2000·Antimicrobial Agents and Chemotherapy·M E KlepserM A Pfaller
Feb 17, 2009·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Nina Naeger-Murphy, James C Pile
Apr 15, 2003·Mycoses·M Ruhnke
Mar 15, 2002·American Journal of Clinical Dermatology·Adam I RubinRichard K Scher
Feb 4, 2006·American Journal of Veterinary Research·Alison B ClodeBrian C Gilger
Oct 27, 2004·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·A M Sugar, X P Liu
Apr 19, 2007·Journal of Basic Microbiology·Chi P NdiMary D Barton
Mar 31, 2005·Archiv der Pharmazie·Paula BoeckSusana Zacchino
Sep 12, 2000·The Annals of Pharmacotherapy·J A Sabo, S M Abdel-Rahman
Aug 7, 2001·Current Treatment Options in Neurology·Lourdes Irizarry
Dec 29, 1998·The American Journal of Hospice & Palliative Care·K BallJ Bagg
Jan 7, 2005·Journal of Clinical Microbiology·Maria José LinaresM Casal
Feb 10, 2004·Journal of Clinical Microbiology·Maria José LinaresManuel Casal
Apr 25, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E K ManavathuP H Chandrasekar
Jul 18, 2003·Clinical Therapeutics·LilyAnn JeuHoratio B Fung
Jan 10, 2002·Infectious Disease Clinics of North America·M A Pfaller, W L Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.